Explore how mesenchymal stem cell therapy offers new hope for cirrhosis patients, with 88.9% improvement rates in clinical trials. Learn about mechanisms, MX1⁺ monocyte reprogramming, and immunomodulatory effects.
Discover how chemical reprogramming transforms human blood cells into pluripotent stem cells (hCiPS): breakthrough technology by Deng Hongkui’s team, clinical advantages over genetic methods, and its revolutionary impact on regenerative medicine.
Stem cell research in 2025 faces ethical challenges like embryo use, cloning, and consent. Explore how science balances progress with societal values.
Explore the latest breakthroughs in stem cell therapy for multiple sclerosis, spinal cord injuries, and ovarian aging. Discover clinical trials, mesenchymal stem cell applications, and China’s pioneering treatments in regenerative medicine
Explore the transformative potential of mesenchymal stem cells (MSCs) in treating rheumatic diseases such as rheumatoid arthritis, lupus, and osteoporosis. Discover their immunomodulatory mechanisms, clinical efficacy, and advantages over other stem cell therapies in this comprehensive analysis.
Explore how China is emerging as the global hub for stem cell therapy, driven by breakthroughs in iPSC technology, cost-effective treatments, and pioneering research led by scientists like Deng Hongkui and Xu Huji. Discover the future of regenerative medicine here.
The study was published by the team of Academician Wang Fusheng from the Fifth Medical Center of PLA General Hospital and the National Clinical Research Center for Infectious Diseases. It further verified the safety and effectiveness of mesenchymal stem cells (MSC) in treating patients recovering from COVID-19, providing new ideas for the treatment of COVID-19.
English
Chinese
French
Spanish